๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Breast Cancer Invasive
Clinical trial register · China

Breast Cancer Invasive Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 7 Guangzhou 3 Zhengzhou 1 Shantou 1
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai7 Guangzhou3 Zhengzhou1 Shantou1
All 4 locations
Target enrolment
to

Breast Cancer Invasive trials in China

11 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
The Association Between Blood Routine Parameters and Breast Cancer Prognosis
NCT07584213Breast Cancer Invasive
Wenjin Yin
Observational
2,946
Shanghai
2026-05-01
Active, closed
The Association of Lunula Status With the Efficacy and Safety of Neoadjuvant Therapy in Breast Cancer
NCT07590570Breast Cancer Invasive
Wenjin Yin
Observational
188
Shanghai
2026-05-01
Active, closed
The Association Between Axillary Lymph Node Metastasis Patterns and Breast Cancer Prognosis
NCT07283718Breast Cancer Invasive
Wenjin Yin
Observational
2,467
Shanghai
2025-09-28
Recruiting
A Phase II Clinical Trial of Artificial Intelligence-assisted One-stop Radiotherapy for Breast Cancer After Breast-conserving Surgery
NCT06686459Breast Cancer Invasive
Sun Yat-sen University
Not applicable
860
Guangzhou
2025-04-06
Recruiting
NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.
NCT06781281Breast Cancer Invasive
Henan Cancer Hospital
Observational
709
Zhengzhou
2024-12-04
Recruiting
GzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast Cancer
NCT06725940Breast Cancer Invasive
Shanghai Jiao Tong University School of Medicine
Observational
50
Shanghai
2024-11-01
Active, closed
Precision Regional Node Irradiation for Sentinel Node-positive Breast Cancer
NCT06583655Breast Cancer Invasive
Ruijin Hospital
Not applicable
205
Shanghai
2024-10-01
Recruiting
Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial
NCT06716073Breast Cancer Invasive
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
1,380
Guangzhou, Shantou
2024-08-01
Active, closed
Neoadjuvant Pyrotinib in HR-positive and HER2-low High-risk Early Breast Cancer
NCT06144944Breast Cancer Invasive, Hormone-receptor-positive Breast Cancer, HER2 Low Breast Carcinoma, Early-stage Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
160
Guangzhou
2024-01-17
Recruiting
Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer
NCT05910398Breast Cancer Invasive
RenJi Hospital
Phase 3
488
Shanghai
2023-06-01
Active, closed
Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
NCT04398914Breast Cancer Invasive
Shanghai Jiao Tong University School of Medicine
Phase 2
216
Shanghai
2020-05-30
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/breast-cancer-invasive

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies listing the condition Breast Cancer Invasive.

How many Breast Cancer Invasive trials are recruiting in China?

5 of the 11 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Breast Cancer Invasive), 11 studies
PhaseStudiesRecruitingShare
Observational5245.5%
Not applicable3227.3%
Phase 32118.2%
Phase 2109.1%

Most active sponsors

Lead sponsors with the most studies (Breast Cancer Invasive)
Lead sponsorStudiesRecruiting
Wenjin Yin30
Shanghai Jiao Tong University School of Medicine21
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University21
Henan Cancer Hospital11
RenJi Hospital11
Ruijin Hospital10
Sun Yat-sen University11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.